NO20014807L - Precursor drugs of thrombin inhibitors - Google Patents

Precursor drugs of thrombin inhibitors

Info

Publication number
NO20014807L
NO20014807L NO20014807A NO20014807A NO20014807L NO 20014807 L NO20014807 L NO 20014807L NO 20014807 A NO20014807 A NO 20014807A NO 20014807 A NO20014807 A NO 20014807A NO 20014807 L NO20014807 L NO 20014807L
Authority
NO
Norway
Prior art keywords
thrombin inhibitors
precursor drugs
precursor
drugs
thrombin
Prior art date
Application number
NO20014807A
Other languages
Norwegian (no)
Other versions
NO20014807D0 (en
Inventor
Dorit Baucke
Helmut Mack
Werner Seitz
Wilfried Hornberger
Gisela Backfisch
Juergen DELZER
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26004346&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20014807(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20014807D0 publication Critical patent/NO20014807D0/en
Publication of NO20014807L publication Critical patent/NO20014807L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00—Formation or introduction of functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO20014807A 1999-04-09 2001-10-03 Precursor drugs of thrombin inhibitors NO20014807L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19915930 1999-04-09
DE10006799 2000-02-15
PCT/EP2000/003008 WO2000061577A1 (en) 1999-04-09 2000-04-05 Prodrugs of thrombin inhibitors

Publications (2)

Publication Number Publication Date
NO20014807D0 NO20014807D0 (en) 2001-10-03
NO20014807L true NO20014807L (en) 2001-12-04

Family

ID=26004346

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014807A NO20014807L (en) 1999-04-09 2001-10-03 Precursor drugs of thrombin inhibitors

Country Status (16)

Country Link
EP (1) EP1169318A1 (en)
JP (1) JP2002541254A (en)
KR (1) KR20020004995A (en)
CN (1) CN1349526A (en)
AU (1) AU3659200A (en)
BG (1) BG105985A (en)
BR (1) BR0009653A (en)
CA (1) CA2368830A1 (en)
HK (1) HK1045516A1 (en)
HU (1) HUP0202431A3 (en)
IL (1) IL145670A0 (en)
NO (1) NO20014807L (en)
PL (1) PL352834A1 (en)
SK (1) SK14092001A3 (en)
TR (1) TR200102914T2 (en)
WO (1) WO2000061577A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10064797A1 (en) * 2000-12-22 2002-06-27 Knoll Ag Combination pack useful for the treatment of e.g. deep vein thrombosis and post-operative thrombosis, containing oral and parenteral formulations of thrombin inhibitor prodrugs
CA2489470A1 (en) * 2002-06-14 2003-12-24 Takeda Pharmaceutical Company Limited Prodrug and process for producing the same
TWI387053B (en) 2004-08-23 2013-02-21 Rokko Systems Pte Ltd Supply mechanism for the chuck of an integrated circuit dicing device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4421052A1 (en) * 1994-06-17 1995-12-21 Basf Ag New thrombin inhibitors, their production and use
CN1198839C (en) * 1995-02-17 2005-04-27 艾伯特有限及两合公司 Novel dipeptide amidines as thrombin inhibitors
DE19631084A1 (en) * 1996-08-01 1998-02-05 Basf Ag Use of (meth) acrylic acid copolymers to increase the permeability of the mucosa
DE19635674A1 (en) * 1996-09-03 1998-03-05 Basf Ag Process for the preparation of amidines

Also Published As

Publication number Publication date
SK14092001A3 (en) 2002-05-09
KR20020004995A (en) 2002-01-16
PL352834A1 (en) 2003-09-08
BG105985A (en) 2002-06-28
TR200102914T2 (en) 2002-01-21
WO2000061577A1 (en) 2000-10-19
NO20014807D0 (en) 2001-10-03
CN1349526A (en) 2002-05-15
AU3659200A (en) 2000-11-14
HUP0202431A3 (en) 2003-03-28
CA2368830A1 (en) 2000-10-19
IL145670A0 (en) 2002-06-30
BR0009653A (en) 2002-01-08
EP1169318A1 (en) 2002-01-09
HK1045516A1 (en) 2002-11-29
HUP0202431A2 (en) 2002-11-28
JP2002541254A (en) 2002-12-03

Similar Documents

Publication Publication Date Title
IS5739A (en) Compounds of unstable DP IV inhibitors
NO20012984D0 (en) Succinoylamino benzodiazepines as inhibitors of AB protein production
NO982809L (en) Drugs of thrombin inhibitors
ID30233A (en) ANTIBIOTICS OF TETOLIDA
DE60002193T2 (en) METALOPROTEASE INHIBITORS
NO20014535D0 (en) Inhibitors of IMPDH enzyme
PT1221918E (en) ADMINISTRATION OF SUB-TENON DRUGS
IL148698A0 (en) INHIBITORS OF FACTOR Xa
NO20016034D0 (en) Inhibitors of aspartyl protease
NO20013965D0 (en) Activation of downhole devices
NO20021090D0 (en) Pharmaceutical solutions of levosimendan
NO20014243L (en) Dihetero-substituted metalloprotease inhibitors
EE200100611A (en) New pharmaceutical combinations of NOS inhibitors
NO20014875D0 (en) Promedients for thrombin inhibitors
IS6347A (en) A mixture of substituted benzimidazoles
EE200100371A (en) Amidinobenzylamine derivatives and their use as thrombin inhibitors
NO20012976L (en) Use of inhibitors of the KQTI channel for the preparation of a drug
PT1189929E (en) FACTOR VIIA INHIBITORS
DE60024101D1 (en) ENZYME INHIBITORS
NO20014807D0 (en) Precursor drugs of thrombin inhibitors
EE200100084A (en) New pharmaceutical uses of NOS inhibitors
NO20013669D0 (en) Reverse hydroxamine inhibitors of matrix metalloproteinases
NO20003799L (en) Incorporation of cholesterol-lowering agents into confectionary dosage forms
EE200100381A (en) New salts of morpholinobenzamide
IT1316440B1 (en) CANNULA DISPENSER OF MEDICINAL OINTMENTS.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application